Asbestos Trust Funds for Alabama Workers
How Alabama steelworkers, shipyard workers, and pipefitters can file asbestos trust fund claims. Key trusts, eligibility, and process.
News & Research
225 articles
Latest mesothelioma updates and data-driven research from peer-reviewed sources
Latest News
legal Asbestos Trust Funds for Michigan Workers
legal Asbestos Trust Funds for Missouri Workers
legal Asbestos Trust Funds for Ohio Workers
legal Asbestos Trust Funds for Wisconsin Workers
legal Asbestos Trust Funds for California Workers
legal Asbestos Trust Funds for Florida Workers
legal Asbestos Trust Funds for Indiana Workers
legal Asbestos Trust Funds for Pennsylvania Workers
legal Asbestos Trust Funds for Tennessee Workers
legal Asbestos Trust Funds for Georgia Workers
legal Asbestos Trust Funds for Iowa Workers
legal Asbestos Trust Funds for New York Workers
legal Asbestos Trust Funds for Illinois Workers
legal $115 Million Birmingham Verdict: Alabama Mesothelioma Cases
legal $2.9 Million and Rising: Michigan Mesothelioma Verdicts
legal $20 Million and Counting: Missouri Mesothelioma Verdicts
legal $27.5 Million and Counting: Ohio Mesothelioma Verdicts
legal Wisconsin Mesothelioma Verdicts and Settlements
legal California Mesothelioma Verdicts and Settlements
legal Florida Mesothelioma Verdicts and Settlements
legal Indiana Mesothelioma Verdicts and Settlements
legal Pennsylvania Mesothelioma Verdicts and Settlements
legal Tennessee Mesothelioma Verdicts and Settlements
legal Georgia Mesothelioma Verdicts and Settlements
legal Iowa Mesothelioma Verdicts and Settlements
legal New York Mesothelioma Verdicts and Settlements
exposure Chicago Steel Mills: The Southeast Side Asbestos Legacy
legal $45 Million and Counting: Illinois Mesothelioma Verdicts
exposure Birmingham Steel, Mobile Ships: Alabama's Asbestos Legacy
exposure Cleveland's Rust Belt Legacy: Steel Mills and Auto Plants That Exposed Thousands
exposure Detroit's Auto Plants: The Asbestos Legacy of Ford, GM, and Chrysler
exposure Paper Mills and Factories: Wisconsin Asbestos Exposure Legacy
exposure St. Louis Manufacturing: A Century of Asbestos Exposure
exposure Steel Mills and Auto Plants: Indiana Asbestos Exposure History
exposure Shipyards and Bases: Florida Asbestos Exposure in Jacksonville, Tampa, and Beyond
exposure Shipyards, Refineries, and Geology: California Asbestos Exposure Legacy
exposure Chemical Plants and Oak Ridge: Tennessee Asbestos Exposure Legacy
exposure Steel Mills and Shipyards: Pennsylvania Asbestos Exposure Legacy
exposure Shipyards and Paper Mills: Georgia Asbestos Exposure Legacy
exposure Manufacturing and Meatpacking: Iowa Asbestos Exposure Legacy
exposure Brooklyn Navy Yard and the WTC: New York City Asbestos Exposure Legacy
research 670 Exposure Sites: Illinois Mesothelioma by the Numbers
research 442 Exposure Sites: Alabama Mesothelioma by the Numbers
research 2,460 Diagnoses: Michigan Mesothelioma by the Numbers
research 273 Exposure Sites: Missouri Mesothelioma by the Numbers
research 127 Exposure Sites: Ohio Mesothelioma by the Numbers
research Highest Rate in the Nation: Wisconsin Mesothelioma by the Numbers
research Most Cases in the Country: California Mesothelioma by the Numbers
research Second in the Nation: Florida Mesothelioma by the Numbers
research Indiana Mesothelioma Rates: Steel Belt Legacy in the Data
research Second Highest Rate in the Nation: Pennsylvania Mesothelioma by the Numbers
research One-Year Filing Deadline: Tennessee Mesothelioma by the Numbers
research Georgia Mesothelioma Data: 4,172 Asbestos Deaths and 74 Exposure Sites
research Twice the National Average: Iowa Mesothelioma by the Numbers
research New York Mesothelioma by the Numbers: 4,732 Cases and Counting
research Asbestos Product Recalls 2026: A Running Global Tally
research Why Immunotherapy Works Differently in Peritoneal Mesothelioma
research Peritoneal vs Pleural Mesothelioma: A 2026 Data Comparison
news $850,000 Settlement for Families After Daycare Asbestos Exposure
research Six Years of Mesothelioma Immunotherapy: From First Approval to 2026
news Blood Clot Biomarkers Could Predict Risk After Mesothelioma Surgery
news Cohesin Gene Mutations Linked to Mesothelioma Recurrence After Surgery
news Asbestos in Children's Sand Products: Eight Countries, Zero US Action
news First ROS1 Fusion in Peritoneal Mesothelioma Responds to Crizotinib
research Asbestos in American Schools: What the 2026 Data Shows
research The Mesothelioma Treatment Landscape in 2026
treatment First PITAC Procedure for Mesothelioma Performed in North America
research MSK Study: Mesothelioma Rising in People Under 50, BAP1 Mutations a Key Factor
research TGF-β Combo Therapy Cuts Mesothelioma Tumor Growth by 70% in Lab Models
exposure Canada Recalls Children's Craft Sand Over Asbestos
legal $30B in Trust Funds: How Much Has Been Paid Out
BREAKING J&J $950M Punitive Damages Overturned in Talc Case
research Mesothelioma Survival Rates by Treatment Type
research 8 Mesothelioma Trials Compared: Results Side by Side
news Asbestos in Craft Sand Closes 450+ Schools in ANZ
news $24.6M Default Judgment in Gold Bond Talc Case
news Pelvic Mesothelioma Shrinks 83% With Immunotherapy
news Durvalumab Plus Chemo Doubles Meso Survival
news UK Trials Proton Beam Therapy for Mesothelioma
news $1.56B Verdict Against J&J in Talc Mesothelioma Case
news UK Recalls Children Sand Toys: Asbestos Found
news Asbestos in Drinking Water: 5x Federal Limit in PA
news Hawaii Identifies L-BAM, Treatable Mesothelioma
research Mesothelioma Rates by State: 2026 Rankings
research Mesothelioma Risk by Occupation: 2026 Data
research 1 in 3 Meso Cases Is a Veteran: Risk by Branch
research CheckMate-743 at Five Years: 14% Still Alive
legal Banjima Launch $1.5B Asbestos Claim Over Wittenoom
legal Talc Claimants Challenge Revlon Bankruptcy Ruling
legal CA Court Rejects San Diego Workers Asbestos Suit
exposure UK Recalls 21+ Toys Over Asbestos in Sand Products
exposure DHS Workers Exposed to Asbestos at DC Demo Site
exposure WA Contractor Fined $200K for Asbestos Violations
legal Vanderbilt Minerals Files Bankruptcy Over Talc
treatment DREAM3R: Durvalumab Plus Chemo Falls Short
legal Smith Law Firm Sues Funders in Talc Cases
legal Philly Jury Finds J&J Liable in Talc Case, $250K
research Baylor-Duke NEMO Trial Tests Immuno Before Surgery
legal BNSF Railway Appeals $8M Libby, Montana Asbestos Verdict
research Blood Test Predicts Immunotherapy Response in Meso
legal $51M Avon Talc Verdict Upheld in Mesothelioma Case
legal $34.2M Verdict Against John Crane in Oregon Shipyard Case
research Mount Sinai P/D Surgery: Zero Mortality in Study
research UCSF Proposes First Peritoneal Meso Staging System
legal $18M Verdict in Florida Brake Dust Mesothelioma Lawsuit
legal Beasley Allen Disqualified From NJ Talc MDL
legal Asbestos Pipe Maker Sues Plaintiff Law Firm
legal $8M Verdict: J&J Talc Mesothelioma Case in Massachusetts
research ADI-PEG20 Phase 3 Trial Shows Promise: ATOMIC-Meso Results
research TEAD Inhibitor IK-930 Shows Activity in Meso
legal J&J Texas Two-Step Fraud Lawsuit Dismissed
research UV1 Vaccine Gets FDA Fast Track for Mesothelioma
clinical-trials Atezolizumab Trial: Phase 1 Study for Mesothelioma
clinical-trials Atezolizumab Phase 3 Trial for Pleural Mesothelioma
clinical-trials Atezolizumab Phase 1 Trial for Pleural Mesothelioma
clinical-trials A2 Bio CAR-T Screening Study (NCT04981119)
clinical-trials A2 Bio CAR-T Phase 1/2 Trial (NCT06051695)
clinical-trials NCI CAR-T Phase 1 Trial (NCT06885697)
clinical-trials CAR-T Trial: Phase 1 Study for Pleural Mesothelioma
clinical-trials UTC CAR-T Phase 1 Trial (NCT06256055)
clinical-trials Immunotherapy Trial: Phase 1 Study for Mesothelioma
clinical-trials NCI HIPEC Phase 1 Trial (NCT04847063)
clinical-trials NCI HIPEC Phase 2 Trial (NCT05001880)
clinical-trials MSK HIPEC Phase 2 Trial (NCT06057935)
clinical-trials Immunotherapy Phase 2 Trial (NCT03935893)
clinical-trials BWH Immunotherapy Phase 2 Trial (NCT05730816)
clinical-trials NCI Immunotherapy Phase 2 Trial (NCT06503146)
clinical-trials MSK Immunotherapy Phase 2 Trial (NCT06477419)
news 92 Mesothelioma Clinical Trials Recruiting in 2026
clinical-trials Nivolumab + Ipilimumab Phase 1/2 Trial (NCT04665206)
clinical-trials Nivolumab + Ipilimumab Phase 2 Trial for Mesothelioma
clinical-trials Nivolumab + Ipilimumab Phase 1/2 Trial (NCT06362369)
clinical-trials Nivolumab + Ipilimumab Trial: Study for Mesothelioma
clinical-trials Nivolumab + Ipilimumab Phase 2 Trial (NCT04400539)
clinical-trials Nivolumab + Ipilimumab Phase 3 Trial (NCT06097728)
clinical-trials Nivolumab + Ipilimumab Phase 1/2 Trial (NCT07121374)
clinical-trials VM Oncology Pembrolizumab Phase 1/2 (NCT03556228)
clinical-trials MSK Pembrolizumab Phase 1 Trial (NCT04897022)
clinical-trials Medicenna Pembrolizumab Phase 1/2 (NCT05086692)
clinical-trials Genmab Pembrolizumab Phase 1/2 (NCT05579366)
clinical-trials Tango Pembrolizumab Phase 1/2 Trial (NCT05732831)
clinical-trials KaliVir Pembrolizumab Phase 1 (NCT06444815)
clinical-trials Pembrolizumab Phase 2 Trial for Pleural Mesothelioma
research Hopkins: Immunotherapy + Surgery Extends Survival
legal $20M Verdict Against J&J in Florida Mesothelioma Case
news The Asbestos Cover-Up: What the Industry Knew in 1930
exposure Your Mechanic May Be Breathing Asbestos Right Now
news 3,000 Americans Die From Mesothelioma Yearly
exposure The Hidden Danger in Your Ceiling
exposure Advocates Sue for East Wing Asbestos Records
research New Review Maps BAP1 Loss in Mesothelioma
exposure UK Recalls Children's Play Sand After Asbestos Found
news UK, EU Split on Talc Cancer Classification
legal $42.6M J&J Talc Verdict in Massachusetts
exposure Montana Windstorm Scatters School Asbestos
BREAKING Cell Therapy Shrinks Tumors in 63%
exposure Cassiar: The Town That Asbestos Built
legal Vi-Jon Talc Mesothelioma Case Settles in California
exposure Cold Lake School Closes After Asbestos Found
asbestos Malaysia Asbestos Ban Push Intensifies
legal $25M Verdict Against J&J in Connecticut Mesothelioma Case
legal U.S. Chamber Urges 5th Circuit to Vacate EPA Asbestos Ban
research Measles Vaccine Gets FDA Orphan Drug for Meso
legal VA Supreme Court: Shipyards Owe Duty to Families
legal J&J Talc Verdicts Top $2.5B in 2025
news Mesothelioma Treatment Advances: 2025
BREAKING Record $1.56B Verdict Against J&J in Talc
legal $65.5M Verdict Against J&J in Minnesota Mesothelioma Case
legal $40M Verdict Against J&J in California Ovarian Cancer Case
research Drug Combo Achieves 60% Response Rate
news FDA Withdraws Talc Asbestos Testing Rule
treatment One Drug Halted, Another Advances
exposure Asbestos in Children's Art Sand: Australia
research Cyncado to Test TT-4 in Australian Meso Trial
legal Judge Allows Experts in 67,500 Talc Cases
exposure Japan Banned Asbestos in 2006, Cases Rise
exposure Minot AFB Missile Crews Face Asbestos Risk
research Mesothelioma Survival: 18-Year Survivor's Story
BREAKING $966M Verdict: J&J Concealed Talc Asbestos Risk
legal $966M Verdict Against J&J in California Mesothelioma Case
news Mesothelioma Awareness Day: September 26
research Mesothelioma Treatment: Hopkins Immunotherapy Trial
treatment VT3989 Doubles Time Without Progression
treatment Hopkins: Pre-Surgery Immunotherapy Success
treatment Trial Tests Immunotherapy Before Surgery
research IMPALA Trial: Light Therapy for Mesothelioma
legal $3.3M Ford Asbestos Brake Verdict Upheld in NY
exposure Paramount Studios Faces Asbestos Suits
legal $117M Asbestos Verdict Sets New York Record
news Asbestos Disclosure Bill H.R.4247
exposure Libby, Montana: America's Deadliest Town
treatment Dual-Target Immunotherapy Shows 52% Response
news UK Commits £1.2B for Asbestos Removal
exposure UK Has World's Highest Meso Rates
exposure Canada Banned Asbestos, Cases Still Rise
treatment FDA Approves Opdivo Qvantig for Mesothelioma
exposure Utah Windstorm Spreads Mine Asbestos
treatment KEYNOTE-483: Keytruda Combo Approved
BREAKING FDA Approves Keytruda Combo for Mesothelioma
news 9/11 Mesothelioma Crisis Still Unfolding
research DENIM Trial: Vaccine Did Not Extend Survival
exposure WHO Classifies Talc as Probable Carcinogen
research MARS 2: Chemo Outperformed Surgery
exposure EPA Bans Chrysotile: First U.S. Asbestos Ban
treatment ATOMIC-Meso: Quadrupled 3-Year Survival
treatment CONFIRM Trial: Nivolumab Extends Survival
news 2023 Mesothelioma Verdicts: $40M+ Awards
news Court Rejects J&J's 2nd Talc Bankruptcy
treatment SynKIR-110 CAR-T Gets FDA Fast-Track
exposure J&J Discontinues Talc Baby Powder
news EPA Proposes Chrysotile Asbestos Ban
news J&J Creates LTL to Shield Talc Liability
legal J&J's Texas Two-Step: 3 Failed Attempts
news FDA OKs Opdivo+Yervoy for Mesothelioma
treatment CheckMate-743: Immunotherapy Beats Chemo
legal $750M Verdict Against J&J in New Jersey Mesothelioma Cases
legal Chris Placitella on 40 Years of Asbestos Trials
exposure FDA Finds Asbestos in J&J Baby Powder
news FDA Approves Optune Lua for Mesothelioma
exposure FDA Finds Asbestos in Claire's Makeup
legal $4.69B Verdict Against J&J in St. Louis Talc Case
exposure Brazil Bans Asbestos in Landmark 2017 Ruling
exposure Lautenberg Act: Path to Asbestos Ban
news Zadroga Act: Permanent Care for 9/11 Responders
Featured Coverage
In-depth reporting, data analysis, and investigations
DATA
Which Asbestos Trust Funds Apply to Texas Workers?
Texas refinery, shipyard, and plant workers may qualify for multiple asbestos trust funds. How claims work and what to expect.